Hack My Net Worth: How Can I Boost My Assets by $40,000?
When Money Gets in the Way of Major Life Decisions
The Right Ways to Split the Bill at a Restaurant
Study: Even Professional Investors Can't Beat the Market
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.